# Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet

> **NCT00518765** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 32 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Aliskiren
- **DRUG:** Aliskiren plus placebo
- **DRUG:** Aliskiren
- **DRUG:** Aliskiren plus placebo

## Key facts

- **NCT ID:** NCT00518765
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2007-08
- **Final completion:** —
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2010-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518765, "Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00518765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*